photo
John G F Cleland

Department of Cardiology, Hull York Medical School, Castle Hill Hospital, University of Hull, Kingston-upon-Hull, UK.


1
John G F Cleland, Stefano Ghio “The determinants of clinical outcome and clinical response to CRT are not the same.”, Heart Fail Rev, vol. 17, no. 6, 2012
View At Pubmed
2
John G F Cleland, Stefano Ghio “The determinants of clinical outcome and clinical response to CRT are not the same.”, Heart Fail Rev, vol. 17, no. 6, 2012
View At Pubmed
3
John G F Cleland, Saqib Mumtaz, Luca Cecchini “Role of antithrombotic agents in heart failure.”, Curr Cardiol Rep, vol. 14, no. 3, 2012
View At Pubmed
4
John G F Cleland, Valentina Carubelli, Teresa Castiello, Ashraf Yassin, Pierpaolo Pellicori, Renjith Antony “Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis.”, Heart Fail Rev, vol. 17, no. 2, 2012
View At Pubmed
5
John G F Cleland, Jacqueline Taylor, Nick Freemantle, Kevin M Goode, Alan S Rigby, Michal Tendera “Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study.”, Eur. J. Heart Fail., vol. 14, no. 5, 2012
View At Pubmed
6
John G F Cleland, Nick Freemantle, Erland Erdmann, Daniel Gras, Lukas Kappenberger, Luigi Tavazzi, Jean-Claude Daubert “Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial.”, Eur. J. Heart Fail., vol. 14, no. 6, 2012
View At Pubmed
7
John G F Cleland, Andrew L Clark “Heart failure--does it matter whether LVEF is reduced?”, Lancet, vol. 380, no. 9851, 2012
View At Pubmed
8
John G F Cleland, Theresa McDonagh, Alan S Rigby, Ashraf Yassin, Tracy Whittaker, Henry J Dargie, “The national heart failure audit for England and Wales 2008-2009.”, Heart, vol. 97, no. 11, 2011
View At Pubmed
9
John G F Cleland, John R Teerlink, Roxy Senior, Evgeny M Nifontov, John J V Mc Murray, Chim C Lang, Vitaly A Tsyrlin, Barry H Greenberg, Jamil Mayet, Darrel P Francis, Tamaz Shaburishvili, Mark Monaghan, Mitchell Saltzberg, Ludwig Neyses, Scott M Wasserman, Jacqueline H Lee, Khalil G Saikali, Cyril P Clarke, Jonathan H Goldman, Andrew A Wolff, Fady I Malik “The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.”, Lancet, vol. 378, no. 9792, 2011
View At Pubmed
10
John G F Cleland, Ashraf S Yassin, Kayvan Khadjooi “Acute heart failure: focusing on acute cardiogenic pulmonary oedema.”, Clin Med, vol. 10, no. 1, 2010
View At Pubmed
11
J G Cleland, L Buga, J Ghosh, M Nasir “Applying evidence-based device care in cardiovascular patients: which patient with heart failure and what device?”, J R Coll Physicians Edinb, vol. 40, no. 3, 2010
View At Pubmed
12
John G F Cleland, Melanie J Calvert, Yves Verboven, Nick Freemantle “Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study.”, Am. Heart J., vol. 157, no. 3, 2009
View At Pubmed
13
John G F Cleland, John J V McMurray, John Kjekshus, Jan H Cornel, Peter Dunselman, Cândida Fonseca, Ake Hjalmarson, Jerzy Korewicki, Magnus Lindberg, Naresh Ranjith, Dirk J van Veldhuisen, Finn Waagstein, Hans Wedel, John Wikstrand, “Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).”, J. Am. Coll. Cardiol., vol. 54, no. 20, 2009
View At Pubmed
14
John Cleland, Nick Freemantle, Stefano Ghio, Friedrich Fruhwald, Aparna Shankar, Monique Marijanowski, Yves Verboven, Luigi Tavazzi “Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.”, J. Am. Coll. Cardiol., vol. 52, no. 6, 2008
View At Pubmed
15
John G F Cleland, Damien Cullington, Olga Khaleva, Ahmed Tageldien “Cardiac resynchronization therapy: dyssynchrony imaging from a heart failure perspective.”, Curr. Opin. Cardiol., vol. 23, no. 6, 2008
View At Pubmed
16
John G F Cleland, Mansour Nasir, Ahmed Tageldien “Cardiac resynchronization therapy or atrio-biventricular pacing-what should it be called?”, Nat Clin Pract Cardiovasc Med, vol. 4, no. 2, 2007
View At Pubmed
17
John G F Cleland, Rhiddian Shelton, Nikolay Nikitin, Sarah Ford, Lars Frison, Margaretha Grind “Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials.”, Eur. J. Heart Fail., vol. 9, no. 6-7, 2007
View At Pubmed
18
John G F Cleland, Periaswamy Velavan, Mansour Nasir “Fighting against sudden death: a single or multidisciplinary approach.”, J Interv Card Electrophysiol, vol. 17, no. 3, 2007
View At Pubmed
19
John Cleland, Ahmed Tageldien, Olga Khaleva, Neil Hobson, Andrew L Clark “Should patients who have persistent severe symptoms receive a left ventricular assist device or cardiac resynchronization therapy as the next step?”, Heart Fail Clin, vol. 3, no. 3, 2007
View At Pubmed
20
John G F Cleland, Stephen L Atkin “Thiazolidinediones, deadly sins, surrogates, and elephants.”, Lancet, vol. 370, no. 9593, 2007
View At Pubmed
21
John G F Cleland, Andrew Charlesworth, Jacobus Lubsen, Karl Swedberg, Willem J Remme, Leif Erhardt, Andrea Di Lenarda, Michel Komajda, Marco Metra, Christian Torp-Pedersen, Philip A Poole-Wilson, “A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET).”, J. Am. Coll. Cardiol., vol. 47, no. 8, 2006
View At Pubmed
22
John G F Cleland “Chronic aspirin therapy for the prevention of cardiovascular events: a waste of time, or worse?”, Nat Clin Pract Cardiovasc Med, vol. 3, no. 5, 2006
View At Pubmed
23
John G F Cleland, Jean-Claude Daubert, Erland Erdmann, Nick Freemantle, Daniel Gras, Lukas Kappenberger, Luigi Tavazzi “Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].”, Eur. Heart J., vol. 27, no. 16, 2006
View At Pubmed
24
John G F Cleland, Michal Tendera, Jerzy Adamus, Nick Freemantle, Lech Polonski, Jacqueline Taylor, “The perindopril in elderly people with chronic heart failure (PEP-CHF) study.”, Eur. Heart J., vol. 27, no. 19, 2006
View At Pubmed
25
John G F Cleland, Alison Coletta, Klaus Witte “Practical applications of intravenous diuretic therapy in decompensated heart failure.”, Am. J. Med., vol. 119, no. 12 Suppl 1, 2006
View At Pubmed
26
John G F Cleland “Patients with treatable malignant diseases--including heart failure--are entitled to specialist care.”, CMAJ, vol. 172, no. 2, 2005
View At Pubmed
27
J G F Cleland, J C Daubert, E Erdmann, N Freemantle, D Gras, L Kappenberger, W Klein, L Tavazzi, “Baseline characteristics of patients recruited into the CARE-HF study.”, Eur. J. Heart Fail., vol. 7, no. 2, 2005
View At Pubmed
28
John G F Cleland, Jean-Claude Daubert, Erland Erdmann, Nick Freemantle, Daniel Gras, Lukas Kappenberger, Luigi Tavazzi, “The effect of cardiac resynchronization on morbidity and mortality in heart failure.”, N. Engl. J. Med., vol. 352, no. 15, 2005
View At Pubmed
29
J G F Cleland, A Torabi, N K Khan “Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction.”, Heart, vol. 91 Suppl 2, 2005
View At Pubmed
30
John G F Cleland, Amala A Louis, Alan S Rigby, Uwe Janssens, Aggie H M M Balk, “Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study.”, J. Am. Coll. Cardiol., vol. 45, no. 10, 2005
View At Pubmed
31
John G F Cleland, John T Sullivan, Stephen Ball, John D Horowitz, Balaji Agoram, Dylan Rosser, Wayne Yates, Lwin Tin, Paulina Fuentealba, Paul B J Burton “Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia: a pharmacokinetic and pharmacodynamic investigation.”, J. Cardiovasc. Pharmacol., vol. 46, no. 2, 2005
View At Pubmed
32
John G F Cleland, Justin Ghosh, Nick Freemantle “Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?”, Nat Clin Pract Cardiovasc Med, vol. 1, no. 1, 2005
View At Pubmed
33
John G F Cleland, Nikolay Nikitin, James McGowan “Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.”, Expert Rev Cardiovasc Ther, vol. 2, no. 1, 2004
View At Pubmed
34
J G F Cleland, I Findlay, S Jafri, G Sutton, R Falk, C Bulpitt, C Prentice, I Ford, Adele Trainer, P A Poole-Wilson “The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure.”, Am. Heart J., vol. 148, no. 1, 2004
View At Pubmed
35
J G F Cleland, A Takala, M Apajasalo, N Zethraeus, G Kobelt “Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.”, Eur. J. Heart Fail., vol. 5, no. 1, 2003
View At Pubmed
36
J G F Cleland, K Swedberg, F Follath, M Komajda, A Cohen-Solal, J C Aguilar, R Dietz, A Gavazzi, R Hobbs, J Korewicki, H C Madeira, V S Moiseyev, I Preda, W H van Gilst, J Widimsky, N Freemantle, Joanne Eastaugh, J Mason, “The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.”, Eur. Heart J., vol. 24, no. 5, 2003
View At Pubmed
37
J G F Cleland “Contemporary management of heart failure in clinical practice.”, Heart, vol. 88 Suppl 2, 2002
View At Pubmed
38
John G F Cleland, Sudipta Chattopadhyay, Aleem Khand, Timothy Houghton, Gerald C Kaye “Prevalence and incidence of arrhythmias and sudden death in heart failure.”, Heart Fail Rev, vol. 7, no. 3, 2002
View At Pubmed
39
J G F Cleland, A Cohen-Solal, J Cosin Aguilar, R Dietz, J Eastaugh, F Follath, N Freemantle, A Gavazzi, W H van Gilst, F D R Hobbs, J Korewicki, H C Madeira, I Preda, K Swedberg, J Widimsky, , “Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.”, Lancet, vol. 360, no. 9346, 2002
View At Pubmed
40
J G Cleland, J C Daubert, E Erdmann, N Freemantle, D Gras, L Kappenberger, W Klein, L Tavazzi, “The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points.”, Eur. J. Heart Fail., vol. 3, no. 4, 2001
View At Pubmed
Keywords
 administration & dosage  Adrenergic beta-Antagonists  adverse effects  Aminobutyrates  analogs & derivatives  Anemia  Angiotensin Receptor Antagonists  Angiotensin-Converting Enzyme Inhibitors  antagonists & inhibitors  Anticoagulants  Arrhythmias, Cardiac  Aspirin  Atrial Fibrillation  Azetidines  Benzylamines  blood  Carbazoles  Cardiac Myosins  Cardiac Output, Low  Cardiac Pacing, Artificial  Cardiac Resynchronization Therapy  Cardiac Resynchronization Therapy Devices  Cardiology  Cardiomyopathy, Dilated  Cardiotonic Agents  Cardiovascular Diseases  Cause of Death  chemically induced  Clinical Trials as Topic  complications  Death, Sudden, Cardiac  Defibrillators, Implantable  diagnosis  Diuretics  Dobutamine  drug therapy  economics  Electric Countershock  epidemiology  Erythropoietin  etiology  Fibrinolytic Agents  Fluorobenzenes  Heart Failure  Heart Failure, Diastolic  Heart Failure, Systolic  Heart-Assist Devices  Hospitalization  Hydrazones  Hydroxymethylglutaryl-CoA Reductase Inhibitors  Hypoglycemic Agents  instrumentation  metabolism  methods  Metoprolol  Mitral Valve Insufficiency  Monitoring, Ambulatory  mortality  Myocardial Infarction  Natriuretic Peptide, Brain  Neprilysin  Pacemaker, Artificial  Patient Selection  Peptide Fragments  Perindopril  Physician's Practice Patterns  physiopathology  Platelet Aggregation Inhibitors  prevention & control  Primary Health Care  Propanolamines  Pulmonary Edema  Pyridazines  Pyrimidines  Quality of Health Care  Quality of Life  Randomized Controlled Trials as Topic  statistics & numerical data  Sulfonamides  surgery  Telemedicine  Tetrazoles  therapeutic use  therapy  Thiazolidinediones  Thrombosis  Urea  Vasodilator Agents  Ventricular Dysfunction, Left  Ventricular Fibrillation  Warfarin

No Biography Available.